{"data":[{"accessionNo":"0000814133-26-000124","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000724004","issuerName":"Mesa Laboratories Inc","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock SH","eventDate":"2026-09-30","reportingPerson":"Wasatch Advisors LP","reportingCik":null,"personType":"IA","sharesOwned":387129,"percentOfClass":6.9,"filedAt":"2026-10-09"},{"accessionNo":"0001193125-26-297483","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-06-30","reportingPerson":"Brian Paul Nelson","reportingCik":null,"personType":"IN,HC","sharesOwned":477126,"percentOfClass":8.6,"filedAt":"2026-07-07"},{"accessionNo":"0001193125-26-297483","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-06-30","reportingPerson":"William Thomas Brennan","reportingCik":null,"personType":"IN,HC","sharesOwned":477126,"percentOfClass":8.6,"filedAt":"2026-07-07"},{"accessionNo":"0001193125-26-297483","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-06-30","reportingPerson":"Long Path Holdings LLC","reportingCik":null,"personType":"OO","sharesOwned":477126,"percentOfClass":8.6,"filedAt":"2026-07-07"},{"accessionNo":"0001193125-26-297483","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-06-30","reportingPerson":"Long Path Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":477126,"percentOfClass":8.6,"filedAt":"2026-07-07"},{"accessionNo":"0001193125-26-297483","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-06-30","reportingPerson":"Long Path Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":477126,"percentOfClass":8.6,"filedAt":"2026-07-07"},{"accessionNo":"0001193125-26-297483","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-06-30","reportingPerson":"Long Path Smaller Companies Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":477126,"percentOfClass":8.6,"filedAt":"2026-07-07"},{"accessionNo":"0001193125-26-156437","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-03-31","reportingPerson":"Long Path Smaller Companies Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":405583,"percentOfClass":7.3,"filedAt":"2026-04-15"},{"accessionNo":"0001193125-26-156437","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-03-31","reportingPerson":"Long Path Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":405583,"percentOfClass":7.3,"filedAt":"2026-04-15"},{"accessionNo":"0001193125-26-156437","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-03-31","reportingPerson":"Long Path Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":405583,"percentOfClass":7.3,"filedAt":"2026-04-15"},{"accessionNo":"0001193125-26-156437","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-03-31","reportingPerson":"Long Path Holdings LLC","reportingCik":null,"personType":"OO","sharesOwned":405583,"percentOfClass":7.3,"filedAt":"2026-04-15"},{"accessionNo":"0001193125-26-156437","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-03-31","reportingPerson":"William Thomas Brennan","reportingCik":null,"personType":"IN,HC","sharesOwned":405583,"percentOfClass":7.3,"filedAt":"2026-04-15"},{"accessionNo":"0001193125-26-156437","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock, no par value","eventDate":"2026-03-31","reportingPerson":"Brian Paul Nelson","reportingCik":null,"personType":"IN,HC","sharesOwned":405583,"percentOfClass":7.3,"filedAt":"2026-04-15"},{"accessionNo":"0000102909-26-001823","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000724004","issuerName":"Mesa Laboratories Inc","ticker":"MLAB","cusip":"59064R109","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27"},{"accessionNo":"0001193125-26-106287","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":null,"securityClass":"Common Stock, no par value","eventDate":"2026-03-11","reportingPerson":"Long Path Smaller Companies Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":311703,"percentOfClass":5.6,"filedAt":"2026-03-13"},{"accessionNo":"0001193125-26-106287","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":null,"securityClass":"Common Stock, no par value","eventDate":"2026-03-11","reportingPerson":"Long Path Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":311703,"percentOfClass":5.6,"filedAt":"2026-03-13"},{"accessionNo":"0001193125-26-106287","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":null,"securityClass":"Common Stock, no par value","eventDate":"2026-03-11","reportingPerson":"Long Path Partners, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":311703,"percentOfClass":5.6,"filedAt":"2026-03-13"},{"accessionNo":"0001193125-26-106287","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":null,"securityClass":"Common Stock, no par value","eventDate":"2026-03-11","reportingPerson":"Long Path Holdings LLC","reportingCik":null,"personType":"OO","sharesOwned":311703,"percentOfClass":5.6,"filedAt":"2026-03-13"},{"accessionNo":"0001193125-26-106287","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":null,"securityClass":"Common Stock, no par value","eventDate":"2026-03-11","reportingPerson":"William Thomas Brennan","reportingCik":null,"personType":"IN,HC","sharesOwned":311703,"percentOfClass":5.6,"filedAt":"2026-03-13"},{"accessionNo":"0001193125-26-106287","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000724004","issuerName":"Mesa Laboratories, Inc.","ticker":"MLAB","cusip":null,"securityClass":"Common Stock, no par value","eventDate":"2026-03-11","reportingPerson":"Brian Paul Nelson","reportingCik":null,"personType":"IN,HC","sharesOwned":311703,"percentOfClass":5.6,"filedAt":"2026-03-13"},{"accessionNo":"0000102909-25-000230","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000724004","issuerName":"Mesa Laboratories Inc","ticker":"MLAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":321717,"percentOfClass":5.84,"filedAt":"2025-10-31"},{"accessionNo":"0002012383-25-001652","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0000724004","issuerName":"MESA LABORATORIES INC","ticker":"MLAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":378897,"percentOfClass":6.9,"filedAt":"2025-10-02"}],"updatedAt":"2026-10-13T07:54:26.080Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}